Olema director granted 29,500 stock options
Olema Pharmaceuticals director Graham G. Walmsley received a new stock option grant for 29,500 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Olema Pharmaceuticals director Graham G. Walmsley received a new stock option grant for 29,500 shares of common stock. The option has an exercise price of $9.51 per share and expires on June 18, 2036. The award vests in 12 equal monthly installments starting June 18, 2026, with any remaining unvested portion vesting in full on the date of Olema’s next annual stockholder meeting, in each case contingent on his continued service. Following this grant, Walmsley holds 29,500 stock options directly.
Insider Trade Summary
Grant/Award: 29,500 shares
Grant/Award
1 txn
Insider
Graham G. Walmsley
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 29,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 29,500 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Stock options granted: 29,500 options
Exercise price: $9.51 per share
Expiration date: June 18, 2036
+3 more
6 metrics
Stock options granted
29,500 options
Grant to director Graham G. Walmsley
Exercise price
$9.51 per share
Stock option strike price for Olema common stock
Expiration date
June 18, 2036
Option term end date
Vesting schedule
12 monthly installments
Equal installments starting June 18, 2026
Post-transaction options held
29,500 options
Total options held directly after grant
Underlying shares
29,500 common shares
Underlying Olema common stock for the option
Key Terms
Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, vest, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest financial
"The shares subject to the option vest in a series of 12 successive equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"Such shares vest in full on the date of the Issuer's next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Olema Pharmaceuticals (OLMA) director Graham G. Walmsley report in this Form 4?
He reported receiving a stock option grant for 29,500 shares. The options relate to Olema common stock, are held directly, and were awarded as compensation rather than purchased in the open market, with vesting tied to his ongoing service on the board.
What are the key terms of Graham G. Walmsley’s new Olema (OLMA) stock options?
The grant covers 29,500 options at a $9.51 exercise price. The options expire on June 18, 2036 and give him the right to buy Olema common shares at that fixed price if vesting and service conditions are satisfied over time.
How do the Olema (OLMA) stock options granted to Graham G. Walmsley vest?
The options vest over 12 equal monthly installments from June 18, 2026. Any remaining unvested portion vests fully on the date of Olema’s next annual stockholder meeting, provided Walmsley continues serving through each applicable vesting date.
How many Olema (OLMA) stock options does Graham G. Walmsley hold after this grant?
After the reported grant, he holds 29,500 stock options directly. The Form 4 shows this as his total option position following the transaction, with no additional remaining derivative positions listed in the derivative holdings summary.
What is the expiration date of Graham G. Walmsley’s Olema (OLMA) stock option grant?
The options expire on June 18, 2036. If any portion of the grant is unexercised by that date, the right to purchase Olema common stock at the $9.51 exercise price will lapse according to the Form 4 disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates